Lazard Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-368
| Closed | -$2K | – | 2295 |
|
|
2025
Q1 | $2K | Sell |
368
-76
| -17% | -$413 | ﹤0.01% | 2200 |
|
|
2024
Q4 | $5K | Buy |
444
+315
| +244% | +$3.55K | ﹤0.01% | 2128 |
|
|
2024
Q3 | $1K | Sell |
129
-179
| -58% | -$1.39K | ﹤0.01% | 2120 |
|
|
2024
Q2 | $2K | Buy |
+308
| New | +$2K | ﹤0.01% | 2097 |
|
|
2023
Q4 | – | Sell |
-285
| Closed | -$10K | – | 2249 |
|
|
2023
Q3 | $10K | Buy |
285
+14
| +5% | +$491 | ﹤0.01% | 2140 |
|
|
2023
Q2 | $10K | Buy |
271
+99
| +58% | +$3.65K | ﹤0.01% | 2180 |
|
|
2023
Q1 | $12K | Sell |
172
-443
| -72% | -$30.9K | ﹤0.01% | 2110 |
|
|
2022
Q4 | $50K | Buy |
615
+138
| +29% | +$11.2K | ﹤0.01% | 1810 |
|
|
2022
Q3 | $45K | Buy |
+477
| New | +$45K | ﹤0.01% | 1832 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | -$1K | – | 1957 |
|
|
2021
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 1821 |
|
|
2020
Q4 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 1801 |
|